Хайлтын үр дүнгүүд - Rinath Jeselsohn

Үр дүнг сайжруулах
  1. 1
    ESR1 fusions and therapeutic resistance in metastatic breast cancer

    ESR1 fusions and therapeutic resistance in metastatic breast cancer -н Zsuzsanna Nagy, Rinath Jeselsohn

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

    PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor–Positive Advanced Breast Cancer -н Erika Hamilton, Rinath Jeselsohn, Linda T. Vahdat, Sara A. Hurvitz

    Хэвлэсэн 2025
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status

    Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status -н Teesha Downton, Fiona H. Zhou, Davendra Segara, Rinath Jeselsohn, Elgene Lim

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

    ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer -н Rinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, Myles Brown, Rachel Schiff

    Хэвлэсэн 2015
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    ESR1 activating mutations: From structure to clinical application

    ESR1 activating mutations: From structure to clinical application -н Albert Grinshpun, Vincent Chen, Zachary M. Sandusky, Sean W. Fanning, Rinath Jeselsohn

    Хэвлэсэн 2022
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer

    The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer -н Albert Grinshpun, Sara M. Tolaney, Harold J. Burstein, Rinath Jeselsohn, Erica L. Mayer

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium

    Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium -н Nelson E. Brown, Rinath Jeselsohn, Teeru Bihani, Miaofen G. Hu, Parthena Foltopoulou, Charlotte Kuperwasser, Philip W. Hinds

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis

    Cyclin D1 Kinase Activity Is Required for the Self-Renewal of Mammary Stem and Progenitor Cells that Are Targets of MMTV-ErbB2 Tumorigenesis -н Rinath Jeselsohn, Nelson E. Brown, Lisa M. Arendt, Ina Klebba, Miaofen G. Hu, Charlotte Kuperwasser, Philip W. Hinds

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade

    Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade -н Otto Metzger, Arlindo R. Ferreira, Rinath Jeselsohn, William T. Barry, Deborah Dillon, Jane E. Brock, Inês Vaz-Luís, Melissa E. Hughes, Eric P. Winer, Nancy U. Lin

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes

    Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes -н Timothy A. Yap, Erika Hamilton, Todd M. Bauer, Ecaterina E. Dumbrava, Rinath Jeselsohn, Aaron Enke, Sabrina Hurley, Kevin K. Lin, Jenn Habeck, Heidi Giordano, Geoffrey I. Shapiro

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells

    PDEF Promotes Luminal Differentiation and Acts as a Survival Factor for ER-Positive Breast Cancer Cells -н Gilles Buchwalter, Michele M. Hickey, Anne Cromer, Laura M. Selfors, Ruwanthi N. Gunawardane, Jason Frishman, Rinath Jeselsohn, Elgene Lim, David Chi, Xiaoyong Fu, Rachel Schiff, Myles Brown, Joan S. Brugge

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer

    Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer -н Sarah Naomi Olsen, Bryn Anderson, Charlie Hatton, Zhengtao Chu, Christopher E. Simpkins, Yanhe Wen, Wallace Bourgeois, Elena Haarer, Myles Brown, Rinath Jeselsohn, Alana L. Welm, Eneda Toska, Scott A. Armstrong

    Хэвлэсэн 2025
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Estrogen receptor signaling is reprogrammed during breast tumorigenesis

    Estrogen receptor signaling is reprogrammed during breast tumorigenesis -н David Chi, Hari Singhal, Lewyn Li, Tengfei Xiao, Weihan Liu, Matthew Pun, Rinath Jeselsohn, Housheng He, Elgene Lim, Raga Vadhi, Prakash K. Rao, Henry W. Long, Judy E. Garber, Myles Brown

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

    D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer -н Keren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel, Addie Dvir, Lior Soussan‐Gutman, Rinath Jeselsohn, Roman Yelensky, Myles Brown, Vincent A. Miller, David Sarid, Shulamith Rizel, Baruch Klein, Tamar Rubinek, Ido Wolf

    Хэвлэсэн 2013
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis

    CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis -н Xintao Qiu, Avery Feit, Ariel Feiglin, Yingtian Xie, Nikolas Kesten, Len Taing, Joseph Perkins, Shengqing Gu, Yihao Li, Paloma Cejas, Ningxuan Zhou, Rinath Jeselsohn, Myles Brown, X. Shirley Liu, Henry W. Long

    Хэвлэсэн 2021
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis

    VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis -н MacIntosh Cornwell, Mahesh Vangala, Len Taing, Zachary T. Herbert, Johannes Köster, Bo Li, Hanfei Sun, Taiwen Li, Jian Zhang, Xintao Qiu, Matthew Pun, Rinath Jeselsohn, Myles Brown, X. Shirley Liu, Henry W. Long

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

    Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer -н Paolo Tarantino, Qingchun Jin, Nabihah Tayob, Rinath Jeselsohn, Stuart J. Schnitt, Julie Vincuilla, Tonia Parker, Svitlana Tyekucheva, Tianyu Li, Nancy U. Lin, Melissa E. Hughes, Anna Weiss, Tari A. King, Elizabeth A. Mittendorf, Giuseppe Curigliano, Sara M. Tolaney

    Хэвлэсэн 2022
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer

    Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer -н Jonathan Goldberg, Na Qiao, Jennifer L. Guerriero, Brett Gross, Yagiz Meneksedag, Yoshimi F. Lu, Anne V. Philips, Tasnim Rahman, Funda Meric‐Bernstam, Jason Roszik, Ken Chen, Rinath Jeselsohn, Sara M. Tolaney, George E. Peoples, Gheath Alatrash, Elizabeth A. Mittendorf

    Хэвлэсэн 2024
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Temporal and spatial topography of cell proliferation in cancer

    Temporal and spatial topography of cell proliferation in cancer -н Giorgio Gaglia, Sheheryar Kabraji, Danae Rammos, Yang Dai, Ana Verma, Shu Wang, Caitlin E. Mills, Mirra Chung, Johann S. Bergholz, Shannon Coy, Jia‐Ren Lin, Rinath Jeselsohn, Otto Metzger, Eric P. Winer, Deborah Dillon, Jean J. Zhao, Peter K. Sorger, Sandro Santagata

    Хэвлэсэн 2022
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer

    Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer -н Yanan Kuang, Bilal A. Siddiqui, Jiani Hu, Matthew Pun, MacIntosh Cornwell, Gilles Buchwalter, Melissa E. Hughes, Nikhil Wagle, Paul Kirschmeier, Pasi A. Jänne, Cloud P. Paweletz, Nancy U. Lin, Ian E. Krop, William T. Barry, Eric P. Winer, Myles Brown, Rinath Jeselsohn

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: